Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26129752 | 0.91 | LMNA (0.41) | ALDH1A1LMNACA12CA1CA9 | |
| SCHEMBL29059636 | 0.91 | LMNA (0.41) | ALDH1A1LMNACA12CA1CA9 | |
| SCHEMBL11864376 | 0.91 | LMNA (0.41) | ALDH1A1LMNACA12CA1CA9 | |
| SCHEMBL31099214 | 0.86 | LMNA (0.39) | ALDH1A1LMNACA12CA1CA9 | |
| SCHEMBL3106202 | 0.85 | FDPS (0.39) | ALDH1A1LMNATSHR | |
| SCHEMBL11195464 | 0.85 | MMP1 (0.34) | ALDH1A1LMNAMMP1MMP2MMP3 | |
| SCHEMBL11193257 | 0.84 | LMNA (0.38) | ALDH1A1LMNAMMP1MMP2MMP3 | |
| SCHEMBL11866792 | 0.80 | LMNA (0.50) | ALDH1A1LMNACA12CA1CA9 | |
| SCHEMBL5181936 | 0.80 | MAPT (0.35) | — | |
| SCHEMBL1041215 | 0.79 | ALDH1A1 (0.39) | ALDH1A1LMNAMMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116249448-B | Antibacterial composition | 株式会社LG化学 | 2026-02-27 | — | — | CN | disclosed |
| US-20250129009-A1 | Compound and Method for Identifying Impurities Included Therein | LG CHEM, LTD. (KR) | 2025-04-24 | — | — | US | disclosed |
| US-20250122144-A1 | Compound and Molded Body Comprising Same | LG CHEM, LTD. (KR) | 2025-04-17 | — | — | US | disclosed |
| CN-118749003-A | Copolymer, antibacterial deodorant composition containing same, and method for producing same | 株式会社LG化学 | 2024-10-08 | — | — | CN | disclosed |
| CN-118510749-A | Compounds and methods for determining impurities contained therein | 株式会社LG化学 | 2024-08-16 | — | — | CN | disclosed |
| CN-118510748-A | Compound and molded body comprising the same | 株式会社LG化学 | 2024-08-16 | — | — | CN | disclosed |
| CN-118475623-A | Antibacterial resin and molded body containing same | 株式会社LG化学 | 2024-08-09 | — | — | CN | disclosed |
| CN-118451115-A | Antibacterial resin, composition for preparing the same, and molded body comprising the same | 株式会社LG化学 | 2024-08-06 | — | — | CN | disclosed |
| CN-116828983-A | antibacterial composition | 株式会社LG化学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116249448-A | Antibacterial composition | 株式会社LG化学 | 2023-06-09 | — | — | CN | disclosed |
| EP-2204394-B1 | PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS | TOSOH CORP (JP) | 2017-07-12 | — | — | EP | disclosed |
| US-8980965-B2 | Method for producing polyester type flexible polyurethane foam, and catalyst composition to be used therefor | TOSOH CORPORATION (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20100256249-A1 | METHOD FOR PRODUCING POLYESTER TYPE FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION TO BE USED THEREFOR | TOSOH CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2204394-A1 | PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS | Tosoh Corporation (JP) | 2010-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256249-A1 | METHOD FOR PRODUCING POLYESTER TYPE FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION TO BE USED THEREFOR | OR51E2, CYP4F11, FFAR3 | ALDH1A1 2369/4885LMNA 3374/4885MMP1 2820/4885 |
| US-20250129009-A1 | Compound and Method for Identifying Impurities Included Therein | MMAB, TET2, AS3MT | ALDH1A1 1551/4885LMNA 92/4885MMP1 4615/4885 |
| US-20250122144-A1 | Compound and Molded Body Comprising Same | ERG28, CYP2E1, CYP51A1 | ALDH1A1 105/4885LMNA 3669/4885MMP1 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.